Catheter Securement Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Manufactured Catheter Securement and 2 Other Segments

Global Catheter Securement Market Report to 2032

The global catheter securement market was valued at $2.2 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.2%, reaching $2.7 billion by 2032.

This report covers the global market for catheter securement, including tape and dressings, manufactured catheter securement devices (MCSDs), and sutures.

The analysis includes unit sales, average selling prices (ASPs), market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.

Market growth is supported by the rising number of catheter insertions, broader adoption of premium securement products, and efforts to reduce infection and catheter-related complications. However, high MCSD prices and competitive pressure are expected to limit stronger market value growth.

Market Overview

The global catheter securement market includes products used to stabilize vascular access devices and reduce the risk of catheter movement, dislodgement, infection, and complications.

The market includes tape and dressings, sutures, and manufactured catheter securement devices. These products are used across peripheral and central vascular access settings, including PIVCs, PICCs, CVCs, midlines, and other catheter types.

Catheter securement is closely tied to the volume of catheter insertions. Since a large share of hospital inpatients receive IV access, securement products are used at high volume across healthcare settings.

Adjunct technologies designed to improve securement effectiveness are supporting incremental market expansion. Adhesive-based securement enhancers and breakaway safety mechanisms illustrate innovation beyond traditional securement platforms. These technologies aim to reduce catheter failure, improve patient safety, and strengthen the value proposition of securement systems across both central and peripheral access settings.

Market Drivers

Increase in the Number of Catheters Inserted

The number of catheters inserted is a major driver of the catheter securement market. Unit sales are closely related to the volume of catheter placements across hospital and alternate care settings.

It is estimated that approximately 90% of all hospital inpatients receive an IV. This makes catheter securement a high-use product category because each catheter placement requires some method of stabilization.

As the world population ages, the number of patients requiring hospitalization, infusion therapy, vascular access, and chronic treatment is expected to increase. This will drive growth in the unit sales of catheter securement products over the forecast period.

Motivation to Reduce Infection and Catheter Complications

The motivation to reduce infection and catheter-related complications is another important driver. Reimbursement changes to Medicare, the Institute for Healthcare Improvement Central Line Bundle guidelines, the Infusion Nurses Society's Standards of Practice, and hospital-led safety initiatives have encouraged adoption of premium products.

These initiatives have resulted in more infection-reducing and complication-reducing products entering the market. Examples include antimicrobial dressings and manufactured catheter securement devices designed to improve catheter stability.

The 5 Million Lives Campaign and PIV 5 Rights also support improved securement for catheter insertion. As healthcare systems continue focusing on infection prevention and complication reduction, the market is expected to benefit from continued adoption of higher-priced securement products.

Adjunct Securement Innovation

Adjunct securement technologies are supporting incremental market growth. These products are designed to enhance securement effectiveness, reduce accidental dislodgement, and improve catheter stabilization.

Examples include adhesive-based securement enhancers from Adhezion Biomedical and breakaway safety mechanisms developed by Lineus Medical. These products reflect ongoing innovation beyond traditional dressings, tape, sutures, and standard MCSDs.

The goal of these technologies is to reduce catheter failure and improve patient safety. As hospitals place more emphasis on vascular access management, these adjunct solutions may become more important across both central and peripheral access settings.

Market Limiters

Relatively High Prices for MCSDs

The relatively high ASP of manufactured catheter securement devices is a major limiter. While MCSD growth is evident, their cost limits wider adoption.

These products are more commonly used with expensive central line catheters, but they are not used as often with PIVCs. Since PIVCs represent the vast majority of catheters placed, MCSDs must further penetrate the PIVC market to drive stronger growth.

It can be difficult to justify a securement device that costs more than double the catheter itself. For broader adoption, prices may need to decline, or detailed cost analysis must show that these products reduce complications, restarts, and total care costs enough to justify the investment.

Competitive Pressures for MCSDs

Competitive pressure in the MCSD market is expected to limit value growth. As more companies enter the segment, leading competitors will attempt to defend market share.

This will likely result in ASP erosion over time. The pressure is especially important for MCSDs used with PIVCs, where securement products are less likely to be bundled in kits compared with PICCs or midlines.

Because PIVC securement devices are often selected separately, healthcare providers can choose the product that works best for them instead of using the device packaged with a catheter. This flexibility can increase competition and place pressure on prices.

Pricing Pressure in Mature Dressing Categories

Tape and dressing products represent a large portion of catheter securement demand, but these categories are mature and highly competitive.

Standard dressings and tapes are widely used, and many healthcare providers are sensitive to price due to the high volume of catheter placements. Even premium antimicrobial dressings must justify their added cost through infection-reduction value.

As procurement teams continue to focus on cost control, pricing pressure in mature dressing categories may limit market value growth. Manufacturers must rely on clinical differentiation, antimicrobial features, and ease-of-use improvements to defend pricing.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
• Qualitative coverage: Market drivers and limiters, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios, and leading competitors.
• Time frame: Base year 2025, forecasts to 2032, and historical data back to 2022.
• Market modeling: Revenue is analyzed using unit sales and ASPs, supported by competitive share analysis and forecast assumptions.
• Device scope: The report covers catheter securement products, including tape and dressings, sutures, manufactured catheter securement devices, antimicrobial dressings, and adjunct securement technologies used across peripheral and central access settings.

Markets Covered and Segmentation

Catheter Securement Market

• Device type: Tape and dressing, suture, and manufactured catheter securement devices.

Tape and dressing products are widely used for catheter stabilization and site protection. This category includes standard dressings, IV securement dressings, antimicrobial dressings, and related adhesive products used across central and peripheral access.

Sutures are used to secure certain catheter types, particularly central access devices. While sutures are established and familiar, the market has been affected by the growth of manufactured securement options that avoid some suture-related drawbacks.

Manufactured catheter securement devices are designed to stabilize catheters without relying only on tape, dressing, or sutures. These devices can reduce catheter movement, dislodgement, and related complications, but their higher price can limit adoption, especially in PIVC use.

Each segment is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.

This segmentation helps manufacturers, investors, and strategy teams understand how securement method, catheter type, pricing, infection prevention, and complication reduction are shaping the global catheter securement market.

Competitive Analysis

In 2025, Solventum emerged as the leading company in catheter securement following its spin-off from 3M in April 2024. The company held the dominant share of the dressing market, especially through its Tegaderm(TM) line.

Products such as Tegaderm(TM) CHG antimicrobial dressing strengthen Solventum's market position, although they are sold at a premium. The company also offers Medipore(TM) dressings, which are widely used for IV securement and wound care.

Solventum also has a presence in manufactured securement devices through its PICC/CVC Securement Device + Tegaderm series. This gives the company a modest but notable share of the MCSD market in addition to its leading dressing position.

Becton Dickinson stood out as the major competitor in the manufactured catheter securement market. Its StatLock(R) line, acquired in 2006, remains the dominant MCSD product family.

BD's strong position in PICC, chronic CVC, and midline catheter markets has enabled it to dominate manufactured securement both independently and within catheter kits. However, competition and hesitance from some competitors to purchase directly from BD have led to some share erosion.

Smith & Nephew held a significant share in the dressings market. Its IV3000(R) dressings are used for IV site care and are available in multiple sizes for peripheral and central line securement. The company also offers IV3000(R) 1-Hand Delivery for easier application and HYPAFIX(R) tape for PIVC securement.

Technology and Practice Trends

Antimicrobial Dressings

Antimicrobial dressings are gaining importance as hospitals focus on infection prevention. Products such as Tegaderm(TM) CHG support premium positioning by combining site protection with antimicrobial functionality.

These products are expected to remain important in central line care.

Manufactured Securement Devices

MCSDs are designed to reduce catheter movement and dislodgement. They are more common with higher-cost catheters such as PICCs, CVCs, and midlines.

Greater PIVC penetration remains a key opportunity but is limited by cost.

Sutureless Securement

Sutureless securement continues to gain attention because it can reduce some risks associated with traditional sutures and simplify catheter stabilization.

This trend supports adoption of manufactured securement platforms.

Adjunct Securement Enhancers

Adjunct securement enhancers are emerging to improve catheter stability beyond standard dressing or securement systems.

These products may reduce catheter failure and accidental dislodgement, supporting better patient safety.

Breakaway Safety Mechanisms

Breakaway safety mechanisms are designed to reduce complications when force is applied to a catheter line. Lineus Medical's technology is an example of innovation aimed at preventing accidental line dislodgement.

These technologies may become more relevant in high-risk care settings.

PIVC Securement Opportunity

PIVCs represent the largest catheter volume base, making PIVC securement an important growth opportunity.

However, MCSD adoption in PIVCs depends on cost justification, clinical evidence, and proof that securement reduces restarts and total care costs.

Geography

This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

Why This Report

• How large is the global catheter securement market today, and how much is it expected to grow through 2032?
• How are tape and dressings, sutures, and manufactured catheter securement devices performing across the forecast period?
• How are unit sales, ASPs, and market values changing over time?
• How does catheter insertion volume drive securement demand?
• What role do antimicrobial dressings and MCSDs play in infection and complication reduction?
• Why are high MCSD prices limiting broader adoption, especially in PIVC use?
• How are competitive pressures affecting ASPs in the MCSD segment?
• What role do adjunct securement enhancers and breakaway safety mechanisms play in future innovation?
• Which companies lead the global catheter securement market?
• How are Solventum, BD, and Smith & Nephew positioned across dressings, MCSDs, and catheter securement products?

The Global Catheter Securement Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand securement innovation, and support commercial planning in the global catheter securement market.